Partager cette information :

Psychedelic-Assisted Psychotherapy for Depression: Everything You Need to Know

12 août 2024

Psychothérapie assistée par la kétamine pour la dépression

Imagine a treatment for depression that works within hours rather than weeks, providing relief for those who have tried countless medications without success. Psychedelic-assisted psychotherapy for depression is rapidly gaining attention as an important option for individuals battling treatment-resistance. With its unique mechanism of action and rapid onset of effects, legal psychedelic medicine offers hope for those seeking an alternative to traditional antidepressants. In this article, we’ll delve into the science behind psychedelic therapy, explore its benefits, and guide you through the treatment process to help you comprendre comment il peut transformer votre parcours de santé mentale.

Qu'est-ce que le psychédélisme ? Therapy and How Does It Work?

There is a low dose anesthetic, a legal psychedelic, which is an N-methyl-D-aspartate (NMDA) receptor antagonist that has been used as an anesthésique pendant des décennies. In recent years, its potential as a rapid-acting antidepressant has gained significant attention in the field of psychiatry. When used at subanesthetic doses, this medicine can produce rapid antidepressant effects.

Psychedelic-Assisted Psychotherapy vs Traditional Antidepressants

Psychothérapie assistée par les psychédéliques représente un changement significatif par rapport à l'année précédente. les traitements antidépresseurs traditionnels. As someone who’s been working in this field for a long time, I can tell you that the medicine’s unique mechanism of action sets it apart from conventional medications, offering hope for those who’ve struggled with treatment-resistant depression.

Début d'action rapide

One of the most striking differences between this medicine and traditional antidepressants is the speed at which it works. While conventional medications often take weeks to show effects, this medicine can provide relief within hours or days. Cet effet antidépresseur rapide est particulièrement important pour les personnes présentant des symptômes dépressifs graves ou des idées suicidaires.

D'après mon expérience, cette rapidité d'action peut changer la vie des patients qui ont attendu des semaines ou des mois pour que les antidépresseurs traditionnels fassent effet.

Mécanisme d'action

The psychedelic medicine’s effectiveness stems from its unique interaction with the brain. Unlike traditional antidepressants that primarily target serotonin, norepinephrine, or dopamine, this medicine works as an N-methyl-D-aspartate (NMDA) receptor antagonist. This mechanism leads to increased glutamate transmission and promotes synaptic plasticity.

What does this mean for you? Essentially, it can help rewire neural pathways, also potentially reversing the damage done by chronic stress and depression. This neuroplasticity-enhancing effect is why many researchers believe it could offer longer-lasting benefits compared to traditional antidepressants particularly when combined with psychotherapy to ingrain new habits of thinking and behaving.

Approche thérapeutique

Psychedelic-assisted psychotherapy combines the biological effects of the medicine with targeted psychotherapy sessions. This integrated approach aims to leverage the increased neuroplasticity induced by the medicine to facilitate deeper therapeutic insights and lasting behavioural changes.

Preuves neurologiques on the medicine’s brain effects show a reduction in activity in the default mode network of the brain. This brain network is the network active when we are at rest and is thought to be involved in mental health conditions. The fixed patterns of thinking and behaving, like rumination and negative thought patterns, are thought to be a part of the default mode network. The medicine réduit temporairement l'activité du réseau en mode par défaut, and improves neuroplasticity. The combination with psychotherapy allows psychedelic therapy to be a potent catalyst for psychological and behavioural change for patients with mental health conditions broadly and depression specifically. 

In contrast, traditional antidepressant treatments, while they may be combined with therapy, may not enhance the therapeutic process in the way psychedelic therapy does. This synergistic effect of psychedelic therapy and psychotherapy could lead to more comprehensive and enduring improvements in mental health.

Types of Depression That May Benefit From Psychedelic-Assisted Psychotherapy

Dépression résistante au traitement

Psychedelic-assisted psychotherapy has shown remarkable potential in treating various forms of depression.

Dépression résistante au traitement

Treatment-resistant depression is perhaps the most well-known candidate for psychedelic therapy. The research base for low dose anesthetic in mental health is the most substantial for treatment resistant depression. In my own practice, I’ve seen patients who’ve tried multiple antidepressants without success find relief with psychedelic therapy. For treatment resistant depression, or those who haven’t responded to two or more traditional antidepressants or psychotherapy, psychedelic therapy offers a new avenue for treatment when other options have been exhausted.

Trouble dépressif majeur

For individuals with major depressive disorder, sometimes referred to by clinicians as “unipolar depression”, psychedelic-assisted psychotherapy can be a life changing treatment option. It’s not just about managing symptoms; it’s about potentially rewiring the brain’s response to stress and negative thought patterns. The N-methyl-D-aspartate (NMDA) receptor antagonist properties of the medicine contribute to its unique mechanism of action.

I’ve observed patients with severe depression experience significant improvements in their mood, energy levels, and overall quality of life after psychedelic therapy treatments. The combination of the medicine’s neuroplasticity-enhancing effects, default mode dampening effects and targeted psychotherapy can lead to more comprehensive and lasting improvements.

Dépression bipolaire

Psychedelic therapy has also shown promise in treating the depressive episodes of trouble bipolaire. This is particularly significant because bipolar depression can be notoriously difficult to treat with conventional antidepressants, particularly in the subtype known as Bipolar type II. In some cases traditional antidepressants may trigger manic episodes. The “affective switch”, or the switch from depression to mania, is a risk which clinicians monitor for. Psychedelic therapy’s rapid action can provide quick relief from depressive symptoms. 

The unique challenges of bipolar disorder necessitate a tailored approach to psychedelic-assisted psychotherapy. While the risk of inducing mania is thought to be low and not seen in clinical trials of psychedelic therapy and bipolar depression, typically patients with bipolar depression are advised to remain on some form of anti manic therapy as a precaution before starting psychedelic-assisted psychotherapy. It’s crucial to note that psychedelic therapy treatment for bipolar depression requires careful monitoring and should only be administered under the supervision of a qualified healthcare provider.

Dépression post-partum

Postpartum depression is a form of depression that follows childbirth and the incidence is thought to be around 12% of pregnancies with significant impairments. Legal, low-dose anesthetics, have been shown to prévenir et réduire l'incidence de la dépression post-partum when given in the period of delivery or soon afterward. One publication reviewing randomized controlled trials cites the medicine with pregnant women undergoing caesarean section without the use of the medicine, those using the medicine in the perioperative period ont montré une diminution du risque de développer une dépression post-partum (48%). These papers are citing studies with single treatments of psychedelic therapy. Given literature on treating depression more broadly, a cumulative series and integrating psychotherapy like Field Trip’s Psychedelic-Assisted Therapy approach may be even more beneficial for those struggling with or at risk for postpartum depression. Indeed, emerging evidence is showing amélioration rapide de la dépression post-partum with psychedelic therapy plus psychotherapy with sustained benefit.  

De nombreuses personnes souffrant de dépression finissent également par avoir des problèmes d'alcoolisme et de toxicomanie. Psychedelic therapy can also treat the different factors that can affect alcohol, depression, and addiction.

Psychedelic Therapy for Depression – Eligibility

Before starting psychedelic therapy, you’ll undergo a comprehensive evaluation by a clinicien prescripteur en santé mentale. This assessment typically includes a review of a patient’s medical history, current medications, and previous treatments for depression. At Field Trip Health, we’ll also conduct a thorough psychiatric evaluation to determine if psychedelic therapy is appropriate for their specific case.

Critères d'éligibilité comprennent souvent un diagnostic de dépression résistante au traitement, ce qui signifie que vous avez essayé plusieurs antidépresseurs ou thérapies sans succès. Nous évaluerons également toute contre-indicationsIl est important de connaître ses antécédents médicaux, tels que certaines maladies cardiovasculaires, une grossesse ou des antécédents de psychose. Il est essentiel de parler ouvertement de vos antécédents médicaux pour garantir votre sécurité pendant le traitement.

Psychédélique Therapy Medication Administration Methods

Une fois qu'ils sont jugés éligibles, nous discutons de la various administration methods. La forme la plus courante est la perfusion intraveineuse, qui offre la biodisponibilité la plus élevée. Toutefois, il existe d'autres options telles que les pulvérisations intranasales (comme Spravato), les injections intramusculaires et les pastilles orales. Le choix dépend de facteurs tels que les antécédents médicaux du patient, ses préférences et les protocoles spécifiques de l'établissement de traitement.

For intravenous administration, patients receive a subanesthetic dose over about 40 minutes to an hour. The dosage is carefully calculated based on their body weight and individual response. Throughout the infusion or dosing session, we’ll monitor the patient’s vital signs and overall well-being. It’s normal to experience mild dissociative effects during treatment, but these typically subside shortly after the infusion ends.

Frequency and Duration of Psychedelic-Assisted Psychotherapy

Fréquence et durée de la psychothérapie assistée par la kétamine

Psychedelic-assisted psychotherapy for depression follows a structured protocol, balancing the need for rapid relief with long-term therapeutic benefits. The frequency and duration of treatments are tailored to each individual’s needs, depression severity, and response to the therapy.

Initial psychedelic therapy treatment phase

The initial phase of psychedelic therapy usually consists of a series of treatments administered over a short period. Most protocols for depression involve 4 to 6 intravenous infusions or dosing sessions given over 2 to 3 weeks. This intensive approach aims to quickly alleviate depressive symptoms and jumpstart the healing process. Les études convergent vers deux fois par semaine pendant trois semaines. being the standard of care in psychedelic therapy for depression. 

D'après mon expérience, au cours de cette phase, de nombreux patients font état d'une amélioration significative de leur humeur, l'anxiété symptoms, and overall well-being. The rapid antidepressant effect of psychedelic therapy can also be beneficial for those experiencing suicidal ideation or severe depression.

Traitement d'entretien

Après la phase de traitement initial, de nombreux patients bénéficieront de traitements d'entretien pour maintenir les effets antidépresseurs. La fréquence de ces séances d'entretien varie considérablement en fonction des besoins et des réponses de chacun. Certains patients peuvent avoir besoin de perfusions ou de séances de dosage mensuelles, tandis que d'autres peuvent maintenir les améliorations avec des traitements tous les quelques mois.

While the data shows that maintenance in some form may prevent relapse, combining psychedelic therapy with psychotherapy may enhance the response and permettent des changements plus durables. In addition, the psychological shifts and often processing of past trauma may reduce the need for maintenance. The psychedelic acts as a catalyst for change, combined with psychotherapy and other therapeutic strategies to achieve lasting improvements in mental health. The decision for maintenance is based on a variety of patient specific factors like treatment response, duration of benefit, the underlying diagnosis, psychological shifts during treatment, and patient finances among others. 

Intégrer la psychothérapie

Psychedelic-assisted psychotherapy isn’t just about the infusions or the medicine on its own. We have seen that taking psychedelic medicine from sterile hospital settings to warm, therapeutic psychotherapy settings has a positive effect on the patient experience. To borrow from the paradigm of psychedelic assisted psychotherapy, the mindset (Set) and Setting of the patient can dramatically change the experience of the medicine for the patient, improving the potential for breakthroughs. Adding a psychotherapy component to psychedelic therapy has been shown in some trials to enhance the effects of the medicine in both effectiveness and duration of effects. Therapy sessions are often scheduled before, during, and after psychedelic therapy treatments to help patients process their experiences and integrate insights into their daily lives.

La fréquence de ces séances de thérapie peut être plus élevée pendant la phase initiale du traitement et diminuer au fur et à mesure que le patient se stabilise. Cependant, un soutien thérapeutique continu est généralement recommandé pour maintenir les progrès et prévenir les rechutes.

Effectiveness of Psychedelic-Assisted Psychotherapy for Depression

Psychedelic-assisted psychotherapy has shown significant effectiveness in treating depression, particularly for those who haven’t responded well to traditional treatments.

Une aide rapide et durable

One of the most striking aspects of psychedelic therapy is its rapid antidepressant effect. Unlike conventional antidepressants that can take weeks to show results, psychedelic therapy often provides relief within hours or days. This quick onset can be life-changing, especially for those grappling with severe depression or suicidal ideation.

Moreover, the combination of psychedelic therapy with psychotherapy may allow for the sustaining of antidepressant response for many patients. Many patients experience sustained improvement in their depression symptoms even after the initial treatment phase. This durability is partly due to the medicine’s unique ability to promote neuroplasticity, essentially helping the brain form new, healthier neural connections, combined with psychotherapy to make those patterns of thinking and behaving more enduring. 

Efficacité dans la dépression résistante au traitement

Psychedelic-assisted psychotherapy has shown particular promise in treating treatment-resistant depression. A significant number of patients who haven’t responded to multiple traditional antidepressants find relief with psychedelic therapy. This effectiveness is backed by numerous clinical trials and real-world evidence.

Recent studies have further solidified psychedelic therapy’s efficacy in treatment-resistant depression. For instance, a study found that the mean change in Montgomery–Åsberg Depression Rating Scale (MADRS) score at day 15 was -18.4 for the medicine compared to -5.7 for placebo. This substantial difference highlights psychedelic therapy’s rapid-acting properties and its potential to provide swift relief for those struggling with severe depressive symptoms.

Moreover, psychedelic therapy has demonstrated effectiveness in bipolar depression, a condition that can be difficult to treat with conventional methods. Adding to the substantial body of evidence, a Étude 2023 showed psychedelic therapy’s non-inferiority to electroconvulsive therapy (ECT) for treatment-resistant depression, without the cognitive les effets secondaires souvent associés à l'ECT. Ce résultat est particulièrement significatif, car il offre une alternative potentiellement plus sûre pour les patients qui pourraient autrement considérer l'ECT comme un dernier recours.

Combiner les approches biologiques et psychologiques

The effectiveness of psychedelic-assisted psychotherapy lies in its dual approach. The infusions or doses work on a biological level, rapidly altering brain chemistry and neural networks to alleviate depressive symptoms. Meanwhile, the psychotherapy component helps patients process their experiences and integrate insights gained during psychedelic therapy sessions into their daily lives.

This combination of pharmacological intervention and targeted psychotherapy creates a synergistic effect. It not only addresses the immediate symptoms of depression but also helps patients develop long-term coping strategies and resilience. As a result, many find that psychedelic-assisted psychotherapy offers a more comprehensive and enduring solution to their depression than medication alone.

How to Find Qualified Psychedelic Therapy Provider

ketamine-assisted-psychotherapy-toronto
La clinique de Toronto de Field Trip Health

When seeking psychedelic therapy, it’s essential to find a prescribing clinician or clinic with experience in this specific treatment. Look for medical professionals who specialize in treatment-resistant depression and have a track record of administering psychedelic therapy. Don’t hesitate to ask about their qualifications, experience, and success rates with psychedelic therapy treatments.

Je recommande de rechercher des cliniques qui proposent soins complets, combining psychedelic dosing sessions with psychotherapy sessions. We take this integrated approach at Visite sur le terrain - Santé, as it yields significantly better treatment outcomes than the medicine alone. Remember, psychedelic therapy is most effective when administered by healthcare providers who understand its unique mechanism of action and can tailor the treatment to your specific needs, along with trained therapists like those at Field Trip Health that can use the psychedelic experience to maximize mental health breakthroughs and transformation.

Psychedelic Therapy Insurance Coverage and Costs

The cost of psychedelic-assisted psychotherapy can vary widely depending on your location and the specific treatment protocol. While psychedelic therapy is becoming more widely accepted, and la couverture d'assurance peut varierAu fil des ans, les régimes d'assurance ont élargi la couverture des soins de santé mentale. Certains régimes d'assurance privés peuvent couvrir tout ou partie du traitement, en particulier lorsqu'il est associé à des séances de psychothérapie.

Many clinics offer package deals for a series of infusions or dosing sessions, which can help reduce overall costs. It’s worth discussing payment options including payment plans that can improve affordability. Remember, while the upfront cost may seem high, psychedelic therapy’s rapid antidepressant effect and potential for long-lasting relief can make it a cost-effective option in the long run, especially for those with treatment-resistant depression.

Health Canada Approved Options: Spravato

In Canada, while psychedelic therapy’s use for depression treatment is considered “off-label,” there is a Health Canada approved option: Spravato. Spravato is a nasal spray form of the medicine that’s been specifically approved for treatment-resistant depression. It’s administered under medical supervision in offices of physicians or prescribers certified by Janssen, the parent company behind Spravato.

However, it’s important to note that many clinicians, myself included, still prefer the generic medicine over Spravato. The general medicine, offers higher bioavailability, has a longer track record of use in depression treatment, is generally more cost effective and may be even more effective than Spravato according to some published evidence. 

Combining Psychedelic Therapy with Lifestyle Changes

Incorporating lifestyle changes can significantly enhance the efficacy of psychedelic therapy. Regular exercise, for instance, has been shown to boost mood and increase neuroplasticity, complementing the medicine’s effects on the brain. I often recommend patients engage in physical activities they enjoy, whether it’s yoga, walking, or more intense workouts.

La nutrition joue également un rôle essentiel. Une alimentation équilibrée, riche en acides gras oméga-3, en vitamines et en minéraux, peut favoriser la santé globale du cerveau. En outre, l'amélioration du sommeil peut renforcer la régulation de l'humeur et les fonctions cognitives, ce qui favorise le processus thérapeutique. La socialisation et l'exposition au soleil sont également bénéfiques pour les patients souffrant de dépression. 

Quelle que soit la principale modalité thérapeutique utilisée, je recommande à tous mes patients souffrant de dépression d'intervenir sur leur mode de vie, notamment par l'exercice, la socialisation, l'activation comportementale (pratique délibérée de certains comportements), une bonne alimentation et une exposition saine au soleil. 

What to Expect During and After Psychedelic-Assisted Psychotherapy

Que peut-on attendre d'une psychothérapie assistée par kétamine ?

Psychedelic-assisted psychotherapy is a unique experience that combines the biological effects of psychedelics with targeted psychological interventions. I’ve guided many patients through this process so let me provide some insights into what you might expect during and after psychedelic-assisted psychotherapy.

During psychedelic-assisted psychotherapy

During an infusion or dosing session, you’ll be in a comfortable, controlled environment. The treatment typically lasts about an hour. You might experience mild dissociative effects, such as se sentir détaché de son corps ou de son environnement. Certains de mes patients signalent des changements visuels ou auditifs, mais ceux-ci sont temporaires et disparaissent peu après la fin de la séance.

Tout au long de la séance, un professionnel de la santé surveillera vos signes vitaux et votre bien-être général. Il est important de se rappeler que si l'expérience peut être intense, elle est aussi brève et soigneusement gérée. De nombreux patients trouvent que ces séances sont profondément introspectives et même transformatrices.

Effets immédiats après le traitement

Immédiatement après la perfusion ou la séance de dosage, vous pouvez vous sentir groggy ou légèrement désorienté. C'est normal et cela disparaît généralement au bout d'une heure ou deux. Certains patients disent se sentir émotionnellement à vif ou vulnérables, tandis que d'autres éprouvent un sentiment de calme ou de clarté. Il est essentiel que quelqu'un vous ramène chez vous après le traitement, car vous ne devez pas conduire de véhicule pendant au moins 24 heures après la perfusion ou la séance.

In terms of mood effects, many patients report rapid improvements in depressive symptoms, often within hours or days of the first treatment. This quick onset of action is one of the most striking aspects of psychedelic therapy, especially for those accustomed to the weeks-long wait associated with traditional antidepressants.

Long-term effects of psychedelic-assisted psychotherapy

The long-term effects of psychedelic-assisted psychotherapy can be profound. Many of our patients experience sustained improvements in mood, anxiety symptoms, and overall quality of life. However, it’s important to note that psychedelic therapy isn’t a “magic bullet.” The most successful outcomes typically involve integrating the insights gained during treatment into daily life through ongoing psychotherapy and lifestyle changes.

In the weeks and months following treatment, you’ll likely continue with regular therapy sessions to process your experiences and build on the progress made. This integration phase is crucial for translating the neuroplasticity-enhancing effects of psychedelics into lasting behavioural and cognitive changes.

Psychedelic-Assisted Psychotherapy at Field Trip Health

At Field Trip Health, we offer an immersive in-person Psychedelic-Assisted Therapy program designed to help you achieve deep breakthroughs and address the root causes of your mental health challenges. Our approach combines the legal psychedelic medicine in low doses for depression with personalized psychotherapy to promote lasting healing and transformation.

At Field Trip Health, we prioritize creating a safe, comfortable environment for your psychedelic therapy sessions. Our team of experienced healthcare professionals closely monitors your progress throughout the treatment process, ensuring your safety and optimizing your therapeutic outcomes.

We’ve established a network of psychedelic therapy clinics across Canada to make psychedelic-assisted treatments more accessible. You can find our clinics in major cities including Toronto, Vancouver, Montreal, Ottawa, Hamilton, and Kitchener Waterloo, as well as in Thunder Bay and Sault Ste. Marie.

Each of our clinics maintains the high standards of care that Field Trip Health is known for, ensuring you receive consistent, quality treatment regardless of which location you choose. Our goal is to make psychedelic-assisted psychotherapy available to those who need it most, providing a new path forward in mental health care.

Field Trip Health propose également des traitements alternatifs en matière de santé mentale, tels que Bloc du ganglion de Stellate thérapie, Thérapie par la MDMAThérapie à la psilocybineThérapie par neurofeedbacket Stimulation magnétique transcrânienne répétitive (SMTr)

A propos de l'auteur

Dr. Mario Nucci

Dr. Mario Nucci MD CCFP est un médecin de famille agréé qui se passionne pour la santé mentale et le développement de nouvelles thérapies. Il est activement engagé dans la recherche avec un poste de professeur associé à l'École de médecine du Nord de l'Ontario et des collaborations de recherche avec l'Université d'Ottawa, l'Université de Calgary, l'Université Lakehead, l'Université Concordia et l'Université de l'île de Vancouver.

Le Dr Nucci est le fondateur du Bay and Algoma Health Centre en 2019, une clinique de médecine sans rendez-vous et de toxicomanie. Il a fondé le Canadian Centre for Psychedelic Healing en 2019, qui opère maintenant sous le nom de Field Trip Health, offrant des soins de santé mentale de pointe dans les régions de l'Atlantique.  Toronto,  Montréal,  Vancouver,  Ottawa, Hamilton, Kitchener-WaterlooThunder BaySault Ste. Marieet à domicile.

fr_CAFR

Commencez dès aujourd'hui votre parcours personnalisé de psychothérapie assistée.